191 related articles for article (PubMed ID: 32325682)
1. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.
Shen N; Zhu B; Zhang W; Nian B; Xu X; Yu L; Ruan X; Chen S; Liu Y; Cao X; Shi X; Li Z; Huang X; Wang X; Chen C; Xiong L; Zhang D; Fu X; Zhang Y
Front Oncol; 2022; 12():891917. PubMed ID: 35600407
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
Nesic M; Bødker JS; Terp SK; Dybkær K
Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
[TBL] [Abstract][Full Text] [Related]
7. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
8. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
[TBL] [Abstract][Full Text] [Related]
9. Effects of Quantification Methods, Isolation Kits, Plasma Biobanking, and Hemolysis on Cell-Free DNA Analysis in Plasma.
Streleckiene G; Forster M; Inciuraite R; Lukosevicius R; Skieceviciene J
Biopreserv Biobank; 2019 Dec; 17(6):553-561. PubMed ID: 31343271
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
[TBL] [Abstract][Full Text] [Related]
11. The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine.
Nel I; Münch C; Shamkeeva S; Heinemann ML; Isermann B; Aktas B
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132253
[TBL] [Abstract][Full Text] [Related]
12. Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits.
Nikitina D; Lukosevicius R; Tilinde D; Muskieta T; Hov JR; Melum E; Klovins J; Org E; Kiudelis G; Kupcinskas J; Skieceviciene J
Biopreserv Biobank; 2024 Feb; ():. PubMed ID: 38416864
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Quantification of Plasma Cell-Free DNA Using Different Manual and Automated Methods.
Polatoglou E; Mayer Z; Ungerer V; Bronkhorst AJ; Holdenrieder S
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292239
[TBL] [Abstract][Full Text] [Related]
14. A New Method for Improving Extraction Efficiency and Purity of Urine and Plasma Cell-Free DNA.
Lin SY; Luo Y; Marshall MM; Johnson BJ; Park SR; Wang Z; Su YH
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33916811
[TBL] [Abstract][Full Text] [Related]
15. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
[TBL] [Abstract][Full Text] [Related]
17. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.
Devonshire AS; Whale AS; Gutteridge A; Jones G; Cowen S; Foy CA; Huggett JF
Anal Bioanal Chem; 2014 Oct; 406(26):6499-512. PubMed ID: 24853859
[TBL] [Abstract][Full Text] [Related]
18. Simple and cost-effective laboratory methods to evaluate and validate cell-free DNA isolation.
Mojtabanezhad Shariatpanahi A; Rokni P; Shahabi E; Varshoee Tabrizi F; Kerachian MA
BMC Res Notes; 2018 Oct; 11(1):757. PubMed ID: 30352614
[TBL] [Abstract][Full Text] [Related]
19. Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma.
Mazurek AM; Fiszer-Kierzkowska A; Rutkowski T; Składowski K; Pierzyna M; Scieglińska D; Woźniak G; Głowacki G; Kawczyński R; Małusecka E
Cancer Biomark; 2013; 13(5):385-94. PubMed ID: 24440979
[TBL] [Abstract][Full Text] [Related]
20. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
Terp SK; Pedersen IS; Stoico MP
J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
